Because separation anxiety is a clinical condition, it is possible to treat
it with a combination of medication and training, also known as behavior modification.
Lilly's Reconcile™ for the treatment of canine separation anxiety
is a chewable flavored tablet given once daily. It is approved by the FDA and has been evaluated at the recommended label
dose for one year.
The most common adverse reactions recorded during clinical trials with Reconcile™ were calm
or lethargy, reduced appetite, vomiting, shaking, diarrhea, restlessness,
excessive vocalization, aggression and, in infrequent cases, seizures. Click here for
important safety information and full product label (PDF).
